PAVmed Inc. Quarterly Cost of Revenue in USD from Q3 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
PAVmed Inc. quarterly/annual Cost of Revenue history and growth rate from Q3 2021 to Q2 2024.
  • PAVmed Inc. Cost of Revenue for the quarter ending June 30, 2024 was $1.67M, a 1.13% decline year-over-year.
  • PAVmed Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $6.8M, a 8.33% increase year-over-year.
  • PAVmed Inc. annual Cost of Revenue for 2023 was $6.42M, a 77.6% increase from 2022.
  • PAVmed Inc. annual Cost of Revenue for 2022 was $3.61M, a 518% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $6.8M $1.67M -$19K -1.13% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $6.82M $1.74M +$398K +29.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $6.42M $1.61M -$9K -0.56% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 $6.43M $1.78M +$153K +9.41% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $6.28M $1.69M +$1.69M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $4.59M $1.35M +$977K +265% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $3.61M $1.62M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 $1.63M +$1.48M +1029% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $369K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 $144K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.